Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Dolutegravir Sodium Tablets (DTG)

NCT07002229 is registered in ClinicalTrials.gov with Henan Genuine Biotech Co., Ltd. as lead sponsor.

NCT NCT07002229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07002229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Dolutegravir Sodium Tablets (DTG)
Lead sponsor
Henan Genuine Biotech Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
December 9, 2021
Completion date
September 9, 2022
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy